The half-life of Selank is an important pharmacokinetic parameter that influences research protocol design, including dosing frequency and timing of endpoint measurements.
Pharmacokinetic Profile
Published research has characterized the pharmacokinetic behavior of Selank across various administration routes and model systems. The half-life can vary depending on the route of administration, the biological model, and other experimental conditions.
Implications for Research Design
Understanding the half-life of Selank helps researchers determine optimal dosing intervals and timing of measurements. Shorter half-life peptides may require more frequent administration, while longer half-life compounds offer extended windows of activity.
Stability Considerations
The in-vivo half-life is distinct from the in-vitro stability of the compound. Proper storage and handling are essential for maintaining the full potency of Selank prior to use in experiments.
Browse our full research peptide catalog at Proxiva Peptides.
Browse the Full Proxiva Catalog
30+ research peptides · 99.9% HPLC-verified purity · Certificate of Analysis included · Same-day shipping from the United States
All products are for laboratory and research use only. Not for human consumption.